Tags

Type your tag names separated by a space and hit enter

Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
Dev Biol Stand. 1986; 65:85-8.DB

Abstract

There was neither a difference in the (low) percentage of only harmless side-reactions nor in the rate of sero-conversions (between 95-100%), when groups of 15 to 24 months old children were vaccinated either with the single components or with a combined MMR + Chickenpox-vaccine of a high potency.

Authors

Just M
No affiliation info available
Berger R
No affiliation info available
Just V
No affiliation info available

MeSH

Antibodies, ViralChickenpox VaccineChild, PreschoolDrug CombinationsHerpesvirus 3, HumanHumansImmunization, SecondaryInfantMeasles VaccineMeasles virusMeasles-Mumps-Rubella VaccineMumps VaccineMumps virusRubella VaccineRubella virusVaccinationVaccines, AttenuatedVaccines, CombinedViral Vaccines

Pub Type(s)

Journal Article

Language

eng

PubMed ID

3030863

Citation

Just, M, et al. "Evaluation of a Combined Measles-mumps-rubella-chickenpox Vaccine." Developments in Biological Standardization, vol. 65, 1986, pp. 85-8.
Just M, Berger R, Just V. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Dev Biol Stand. 1986;65:85-8.
Just, M., Berger, R., & Just, V. (1986). Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Developments in Biological Standardization, 65, 85-8.
Just M, Berger R, Just V. Evaluation of a Combined Measles-mumps-rubella-chickenpox Vaccine. Dev Biol Stand. 1986;65:85-8. PubMed PMID: 3030863.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. AU - Just,M, AU - Berger,R, AU - Just,V, PY - 1986/1/1/pubmed PY - 1986/1/1/medline PY - 1986/1/1/entrez SP - 85 EP - 8 JF - Developments in biological standardization JO - Dev Biol Stand VL - 65 N2 - There was neither a difference in the (low) percentage of only harmless side-reactions nor in the rate of sero-conversions (between 95-100%), when groups of 15 to 24 months old children were vaccinated either with the single components or with a combined MMR + Chickenpox-vaccine of a high potency. SN - 0301-5149 UR - https://www.unboundmedicine.com/medline/citation/3030863/Evaluation_of_a_combined_measles_mumps_rubella_chickenpox_vaccine_ L2 - https://www.diseaseinfosearch.org/result/6369 DB - PRIME DP - Unbound Medicine ER -